Related Experiment Video
Updated: Mar 6, 2026
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Down-regulation of miR-124 target protein SCP-1 inhibits neuroglioma cell migration
1Department of Neurosurgery, The People's Hospital of Linyi, Shandong, China. bingli2016tu@163.com.
Objective:
MicroRNAs (miRNAs) have been widely studied as a potential cancer agent, but its efficacy does not get improvement due to poor targeting. miRNAs have been reported to play multiple roles in the development of the tumor. miR-124 is expressed in various tumor. This study aimed to elucidate the expression of miR-124 in neuroglioma cells as well as its related mechanism.
Materials And Methods:
Expression of miR-124 in neuroglioma cells was assessed by Quantitative PCR (q-PCR). Astrocytes (RA cells) were used as control group. The relationship between miR-124 and SCP-1 was explored with bioinformatics tools. Luciferase reporter assay was performed to examine the expression of miR-124 target protein SCP-1. Gene interference technology was used to regulate expression of miR-124 and SCP-1 in neuroglioma cells, and q-PCR was performed to confirm gene interference effects. Migration of miR-124 and SCP-1 in neuroglioma cell was measured by wound healing assay and cell migration test.
Results:
Compared with control group, the expressions of miR-124 (p=0.0015) and SCP-1 (p=0.0042) were higher in neuroglioma cells. Luciferase reporter assay proved that SCP-1 was the target of miR-124. Wound healing assay and migration test showed down-regulation of SCP-1 inhibited neuroglioma cell migration. Down-regulation of miR-124 didn't influence neuroglioma cell migration movement.
Conclusions:
miR-124 and SCP-1 in neuroglioma cell were highly expressed. MiR-124 impeded the progression of neuroglioma via down-regulating SCP-1.
Insights
MicroRNA-124 (miR-124) and SCP-1 are highly expressed in neuroglioma. MiR-124 inhibits neuroglioma progression by down-regulating SCP-1, offering a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- MicroRNAs (miRNAs) are implicated in tumor development, yet their therapeutic efficacy is limited by poor targeting.
- miR-124 is frequently detected in various tumors, suggesting a role in cancer progression.
- Understanding miR-124's function in neuroglioma is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the expression levels of miR-124 in neuroglioma cells.
- To elucidate the mechanism underlying miR-124's role in neuroglioma.
- To identify potential therapeutic targets for neuroglioma treatment.
Main Methods:
- Quantitative PCR (q-PCR) to assess miR-124 and SCP-1 expression.
- Bioinformatics and luciferase reporter assays to confirm SCP-1 as a miR-124 target.
- Gene interference and cell migration assays (wound healing, migration test) to evaluate functional impact.
Main Results:
- Both miR-124 and SCP-1 showed significantly higher expression in neuroglioma cells compared to controls.
- SCP-1 was validated as a direct target of miR-124.
- Down-regulation of SCP-1 effectively inhibited neuroglioma cell migration, while miR-124 down-regulation had no significant effect on migration.
Conclusions:
- miR-124 and SCP-1 are overexpressed in neuroglioma.
- MiR-124 suppresses neuroglioma progression by targeting and down-regulating SCP-1.
- This interaction presents a potential therapeutic strategy for neuroglioma.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs